An ongoing surveillance program was intensified to determine whether an increased risk of acquiring vaccine-related Guillain-Barre syndrome (GBS) (similar to that observed after vaccination with the A/New Jersey swine-influenza vaccine in 1976) existed for the approximately 12.5 million adults (greater than or equal to 18 years old) vaccinated in the 1978-1979 influenza campaign. In the contiguous United States (excluding Maryland) 544 cases of GBS with onset between September 1, 1978, and March 31, 1979, were reported, including 12 adults who had been vaccinated within eight weeks before the onset of GBS and 393 who had not. The relative risk of vaccine-associated GBS for adults reported in this surveillance was 1.4 (95% confidence limits, 0.7 to 2.7)--significantly below the risk (6.2) associated with A/New Jersey vaccine for the equivalent eight-week period. In contrast to the A/New Jersey vaccine, the 1978-1979 influenza vaccine was not associated with a statistically significant excess risk of GBS.
This article has been cited by other articles:
Stowe, J., Andrews, N., Wise, L., Miller, E.
(2008). Investigation of the Temporal Association of Guillain-Barre Syndrome With Influenza Vaccine and Influenzalike Illness Using the United Kingdom General Practice Research Database. Am J Epidemiol
0: kwn310v1-kwn310
[Abstract][Full Text]
Juurlink, D. N., Stukel, T. A., Kwong, J., Kopp, A., McGeer, A., Upshur, R. E., Manuel, D. G., Moineddin, R., Wilson, K.
(2006). Guillain-Barre Syndrome After Influenza Vaccination in Adults: A Population-Based Study.. Arch Intern Med
166: 2217-2221
[Abstract][Full Text]
Haber, P., DeStefano, F., Angulo, F. J., Iskander, J., Shadomy, S. V., Weintraub, E., Chen, R. T.
(2004). Guillain-Barre Syndrome Following Influenza Vaccination. JAMA
292: 2478-2481
[Abstract][Full Text]
Committee on Infectious Diseases,
(2004). Recommendations for Influenza Immunization of Children. Pediatrics
113: 1441-1447
[Abstract][Full Text]
Madjid, M., Naghavi, M., Litovsky, S., Casscells, S. W.
(2003). Influenza and Cardiovascular Disease: A New Opportunity for Prevention and the Need for Further Studies. Circulation
108: 2730-2736
[Full Text]
Rennels, M. B., Meissner, H. C., Committee on Infectious Diseases,
(2002). Technical Report: Reduction of the Influenza Burden in Children. Pediatrics
110: e80-e80
[Abstract][Full Text]
Committee on Infectious Diseases,
(2002). Reduction of the Influenza Burden in Children. Pediatrics
110: 1246-1252
[Abstract][Full Text]
Couch, R. B.
(2000). Prevention and Treatment of Influenza. NEJM
343: 1778-1787
[Full Text]
Seneviratne, U.
(2000). Guillain-Barre syndrome. Postgrad. Med. J.
76: 774-782
[Abstract][Full Text]
Lasky, T., Terracciano, G. J., Magder, L., Koski, C. L., Ballesteros, M., Nash, D., Clark, S., Haber, P., Stolley, P. D., Schonberger, L. B., Chen, R. T.
(1998). The Guillain-Barre Syndrome and the 1992-1993 and 1993-1994 Influenza Vaccines. NEJM
339: 1797-1802
[Abstract][Full Text]
Beghi, E., Kurland, L. T., Mulder, D. W., Wiederholt, W. C.
(1985). Guillain-Barre Syndrome: Clinicoepidemiologic Features and Effect of Influenza Vaccine. Arch Neurol
42: 1053-1057
[Abstract]
